The median time to first reach HbA1c 6.5% was 12.1 weeks for each tirzepatide dose compared with 24.1 weeks for insulin degludec (HR [95% CI] 2.21 [1.84, 2.65], 2.36 [1.96, 2.84], and 2.59 [2.15, 3.12], respectively, for the 5, 10, and 15 mg doses of tirzepatide
Liraglutide mimics the action of the GLP-1 hormone found in your body
Useful angiogenesis endpoints include: VEGF expression VEGFR2 pathway markers CD34 staining factor VIII staining endothelial cell response new vessel organisation blood flow related tissue markers A 2009 study looked at BPC-157 in relation to VEGF expression and angiogenic behaviour across cell culture and tissue injury models
Utilization data shows what problems patients believe these drugs are solving
doi: 10.1002/oby.23752 57